WallStreetZenWallStreetZen

NASDAQ: SHC
Sotera Health Co Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sotera Health Co earnings were $77.9M for the trailing 12 months ending Dec 31, 2025, with 68.8% growth year over year. The latest SHC earnings report on Dec 31, 2025 announced Q4 2025 earnings of $34.8M, down 28% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SHC reported annual earnings of $77.9M, with 75.6% growth. The next SHC earnings date is Apr 30, 2026.

SHC past earnings growth

How has SHC's earnings growth performed historically?

Company
68.75%
Industry
10.27%
Market
87.01%
SHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SHC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SHC earnings history

Current Revenue
$1.2B
Current Earnings
$77.9M
Current Profit Margin
6.7%

SHC Return on Equity

Current Company
15%
Current Industry
-2.2%
Current Market
28.9%
SHC's Return on Equity (15%)... subscribe to Premium to read more.
High Return on Equity Performance

SHC Return on Assets

Current Company
2.4%
Current Industry
6.4%
SHC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SHC announces earnings.

SHC Return on Capital Employed

Current Company
10.06%
Current Industry
13.3%
SHC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SHC vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SHC$439.93M$77.95M-9.92%$0.27
BLLN$19.76M$2.92MN/A$0.18
RDNT$278.12M-$18.65MN/A-$0.25
TWST-$50.92M-$76.58MN/A-$1.27
CAI$16.97M-$537.96MN/A-$3.22
View Top Diagnostic & Research Stocks

SHC earnings dates

Next earnings date
Apr 30, 2026

Sotera Health Co Earnings Reports & History FAQ

What were Sotera Health Co's earnings last quarter?

On SHC's earnings call on Invalid Date, Sotera Health Co (NASDAQ: SHC) reported Q4 2025 earnings per share (EPS) of $0.12, up 140% year over year. Total SHC earnings for the quarter were $34.85 million. In the same quarter last year, Sotera Health Co's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Sotera Health Co stock.

When does Sotera Health Co report earnings?

The next SHC earnings date is Invalid Date. Add SHC to your watchlist to be reminded of Sotera Health Co's next earnings date.

Is Sotera Health Co profitable or losing money?

As of the last Sotera Health Co earnings report, Sotera Health Co is currently profitable. Sotera Health Co's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $77.95 million, a 75.57% increase year over year.

What was SHC's earnings growth in the past year?

As of Sotera Health Co's earnings date in Invalid Date, Sotera Health Co's earnings has grown 68.75% year over year. This is 58.48 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.27%. SHC earnings in the past year totalled $77.95 million.

What are Sotera Health Co's earnings expectations?

The current EPS estimate for Sotera Health Co's earnings report in Invalid Date is $0.17.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.